Actionable news
0
All posts from Actionable news
Actionable news in S: SPRINT CORPORATION,

Pre-Market Earnings Report for October 25, 2016 : PG, MRK, MMM, LLY, UTX, LMT, DD, CAT, GM, MMC, BAX, S

The following companies are expected to report earnings prior to market open on 10/25/2016. Visit our Earnings Calendar for a full list of expected earnings releases.

Procter & Gamble Company ( PG ) is reporting for the quarter ending September 30, 2016. The cleaning company's consensus earnings per share forecast from the 11 analysts that follow the stock is $0.98. This value represents a no change for the same quarter last year. In the past year PG has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 6.76%. Zacks Investment Research reports that the 2017 Price to Earnings ratio for PG is 21.73 vs. an industry ratio of 22.50.

Merck & Company, Inc. ( MRK ) is reporting for the quarter ending September 30, 2016. The large cap pharmaceutical company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.98. This value represents a 2.08% increase compared to the same quarter last year. In the past year MRK has beat the expectations every quarter. The highest one was in the 2nd calendar quarter where they beat the consensus by 1.09%. Zacks Investment Research reports that the 2016 Price to Earnings ratio for MRK is 16.36 vs. an industry ratio of 17.10.

3M Company ( MMM ) is reporting for the quarter ending September 30, 2016. The diversified operations company's consensus earnings per share forecast from the 8 analysts that follow the stock is $2.14. This value represents a 4.39% increase compared to the same quarter last year. In the past year MMM has met analyst expectations once and beat the expectations the other three quarters. Zacks Investment Research reports that the 2016 Price to Earnings ratio for MMM is 20.60 vs. an industry ratio of 21.10.

Eli Lilly and Company ( LLY ) is reporting for the quarter ending September 30, 2016. The large cap pharmaceutical company's consensus earnings per share forecast from the 10 analysts that follow the stock is $0.96. This value represents a 7.87% increase compared to the same quarter last year. LLY missed the consensus earnings per share in the 1st calendar quarter of 2016...


More